• News

"New Tools For Depression"

  • Proto Magazine
  • New York, NY
  • (June 18, 2018)

Helen Mayberg, MD, senior faculty of neurosurgery, neurology, psychiatry, neuroscience and director of the Center for Advanced Circuit Therapeutics at the Icahn School of Medicine at Mount Sinai, has conducted a series of brain-imaging studies to find biomarkers that will predict which patients are most likely to respond to a certain approach. Using positron emission tomography (PET) and functional magnetic resonance imaging, Dr. Mayberg has found distinct patterns of neural activity and connectivity in people who get better taking antidepressants versus those who respond to CBT. The diagnostics can help predict optimal treatments as well as which ones to avoid.

- Helen Mayberg, MD, Senior Faculty, Neurosurgery, Neurology, Psychiatry, Neuroscience, Icahn School of Medicine at Mount Sinai, Director, The Center for Advanced Circuit Therapeutics, Mount Sinai Health System

Learn more